L. Moreau

Phase II Comparator Study of Oral Versus Intravenous Topotecan in Patients With Chemosensitive Small-Cell Lung Cancer

Joachim von Pawel, U. Gatzemeier, Jean-Louis Pujol et al. · Journal of Clinical Oncology · 2001 · 233 citations

Medicine, Oncology, Pharmacology +11

Risk factors for Coronavirus Disease 2019 (COVID-19) severity and mortality among solid cancer patients and impact of the disease on anticancer treatment: A French nationwide cohort study (GCO-002 CACOVID-19)

Astrid Lièvre, Anthony Turpin, Isabelle Ray‐Coquard et al. · European Journal of Cancer · 2020 · 164 citations · Full text

Medicine, Infectious Diseases, Oncology +14

Overall survival with crizotinib and next-generation ALK inhibitors in <i>ALK</i>-positive non-small-cell lung cancer (IFCT-1302 CLINALK): a French nationwide cohort retrospective study

M. Duruisseaux, Benjamin Besse, J. Cadranel et al. · Oncotarget · 2017 · 162 citations · Full text

Medicine, Oncology, Pharmacology +14

First-Line Camizestrant for Emerging <i>ESR1</i> -Mutated Advanced Breast Cancer

François‐Clément Bidard, Erica L. Mayer, Yeon Hee Park et al. · New England Journal of Medicine · 2025 · 110 citations · Full text

Medicine, Oncology, Pharmacology +16

Pre-operative systemic (neo-adjuvant) therapy with trastuzumab and docetaxel for HER2-overexpressing stage II or III breast cancer: results of a multicenter phase II trial

Bruno Coudert, Laurent Arnould, L. Moreau et al. · Annals of Oncology · 2005 · 95 citations

Medicine, Oncology, Pharmacology +16